<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01432496</url>
  </required_header>
  <id_info>
    <org_study_id>AR HSG 06 2010 Colectomy</org_study_id>
    <nct_id>NCT01432496</nct_id>
  </id_info>
  <brief_title>Peritoneal Nebulization of Ropivacaine for Pain Control After Laparoscopic Colectomy</brief_title>
  <official_title>A Multicentric, Randomized, Controlled, Double Blinded, Phase III Clinical Trial; Comparing Peritoneal Nebulization of Ropivacaine 150 mg With Peritoneal Nebulization of Saline</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>San Gerardo Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University of Milano Bicocca</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Azienda Ospedaliera di Lecco</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>IRCCS Policlinico S. Matteo</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Pavia</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>San Gerardo Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to assess if intraperitoneal nebulization of Ropivacaine 150 mg
      produces better postoperative pain control than Saline nebulization after laparoscopic
      colectomy.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Recently intraperitoneal nebulization of local anesthetic has been used as an alternative to
      direct intraperitoneal instillation. Intraperitoneal aerosolization of Bupivacaine 50 mg
      after laparoscopic cholecystectomy significantly reduced postoperative pain, morphine
      consumption and incidence of postoperative nausea and vomiting and it is associated with
      rapid mobilization compared with patients receiving direct instillation of Bupivacaine 50 mg
      or placebo.

      In a recent study the investigators found that nebulization of Ropivacaine 30 mg with the
      AeronebProÂ® before or after laparoscopic cholecystectomy and gynecologic laparoscopic surgery
      reduces postoperative pain and morphine consumption. Patients receiving preoperative
      nebulization of Ropivacaine presented significantly less postoperative pain (-50% clinical
      setting) and consumed significant less morphine (-50% and -40% respectively) than patients in
      control groups during the first 48 hours after surgery.

      The effects of peritoneal nebulization of ropivacaine during laparoscopic colectomy on pain
      control and morphine consumption were not evaluated.

      The investigators hypothesize that intraperitoneal nebulization of Ropivacaine may produce
      better pain control and less morphine consumption than nebulization of saline after
      laparoscopic colectomy.
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    There was insuficient recruitment in two centers
  </why_stopped>
  <start_date>September 2011</start_date>
  <completion_date type="Actual">December 2012</completion_date>
  <primary_completion_date type="Actual">December 2012</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Postoperative pain</measure>
    <time_frame>72 hours</time_frame>
    <description>Numeric Ranking Scale (NRS 0 to 10 points) at rest (static NRS) and after a deep inspiration or cough (dynamic NRS) in PACU and at 6, 24, 48 and 72 hours after the discharge from PACU.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Time of unassisted walking</measure>
    <time_frame>72 hours</time_frame>
    <description>Unassisted walking time is defined as the time in hours between PACU discharge and when the patient is able to walk out of his room and back to bed without any assistance.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Return to active bowel function</measure>
    <time_frame>72 hours</time_frame>
    <description>The return of bowel function will be assessed using two parameters: time of first flatus and time of first bowel movement.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hospital morbidity</measure>
    <time_frame>72 hours</time_frame>
    <description>All complications or adverse effects associated or possibly associated with the interventions under study, surgery or anesthesia will be quantified</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time and condition for hospital discharge</measure>
    <time_frame>72 hours</time_frame>
    <description>Time in days elapsed between surgery and hospital discharge.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Analgesic consumption</measure>
    <time_frame>72 hours</time_frame>
    <description>The total dose of morphine will be quantified using the PACU clinical chart and/or PCA infusers memory display</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">130</enrollment>
  <condition>Postoperative Pain</condition>
  <arm_group>
    <arm_group_label>Ropivacaine 150 mg</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Nebulization of Ropivacaine 150 mg in the peritoneal cavity with the Aeroneb Pro system</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Saline 15 ml</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Nebulization of Saline 15 ml in the peritoneal cavity with the Aeroneb Pro system</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ropivacaine 150 mg</intervention_name>
    <description>Nebulization of Ropivacaine 150 mg in the peritoneal cavity</description>
    <arm_group_label>Ropivacaine 150 mg</arm_group_label>
    <other_name>Nebulization Ropivacaine</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>saline 15 ml</intervention_name>
    <description>Nebulization of saline 15 ml in the peritoneal cavity</description>
    <arm_group_label>Saline 15 ml</arm_group_label>
    <other_name>Nebulization Saline</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Females and Males 18-80 years old

          -  ASA Score I (American Society of Anesthesiologists classification : a normal healthy
             patient.

          -  ASA Score II (American Society of Anesthesiologists classification): A patient with
             mild systemic disease

          -  ASA Score III (American Society of Anesthesiologists classification): A patient with
             severe systemic disease

          -  Patients scheduled for oncological laparoscopic colectomy

          -  Patients who do not use opioids analgesic drugs before surgery

          -  Patients without cognitive impairment or mental retardation

        Exclusion Criteria:

          -  Females and Males under 18 or over 80

          -  ASA Score IV (American Society of Anesthesiologists classification): A patient with
             severe systemic disease that is a constant threat to life

          -  ASA Score V (American Society of Anesthesiologists classification): A moribund patient
             who is not expected to survive without the operation

          -  Emergency/urgency surgery

          -  Postoperative admission in an intensive care unit with sedation or ventilatory
             assistance

          -  Cognitive impairment or mental retardation

          -  Use of opiods before surgery

          -  Progressive degenerative diseases of the CNS

          -  Convulsions or chronic therapy with antiepileptic drugs

          -  Severe hepatic or renal impairment

          -  Allergy to one of the specific drugs under study

          -  Acute infection or inflammatory chronic disease

          -  Alcohol or drug addiction

          -  Any kind of communication problem

          -  Neurologic or psychiatric disease
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Pablo M Ingelmo, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>San Gerardo Hospital, MB, Italy</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Azienda Ospedaliera di Lecco. Presidio &quot;A.Manzoni&quot;</name>
      <address>
        <city>Lecco</city>
        <state>LC</state>
        <zip>23900</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>San Gerardo Hospital</name>
      <address>
        <city>Monza</city>
        <state>MB</state>
        <zip>20052</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Fondazione IRCCS Policlinico San Matteo</name>
      <address>
        <city>Pavia</city>
        <state>PV</state>
        <zip>27100</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <reference>
    <citation>Alkhamesi NA, Peck DH, Lomax D, Darzi AW. Intraperitoneal aerosolization of bupivacaine reduces postoperative pain in laparoscopic surgery: a randomized prospective controlled double-blinded clinical trial. Surg Endosc. 2007 Apr;21(4):602-6. Epub 2006 Dec 16.</citation>
    <PMID>17180268</PMID>
  </reference>
  <reference>
    <citation>Greib N, Schlotterbeck H, Dow WA, Joshi GP, Geny B, Diemunsch PA. An evaluation of gas humidifying devices as a means of intraperitoneal local anesthetic administration for laparoscopic surgery. Anesth Analg. 2008 Aug;107(2):549-51. doi: 10.1213/ane.0b013e318176fa1c.</citation>
    <PMID>18633034</PMID>
  </reference>
  <reference>
    <citation>Schlotterbeck H, Schaeffer R, Dow WA, Diemunsch P. Cold nebulization used to prevent heat loss during laparoscopic surgery: an experimental study in pigs. Surg Endosc. 2008 Dec;22(12):2616-20. doi: 10.1007/s00464-008-9841-z. Epub 2008 Mar 18.</citation>
    <PMID>18347861</PMID>
  </reference>
  <verification_date>February 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 9, 2011</study_first_submitted>
  <study_first_submitted_qc>September 12, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 13, 2011</study_first_posted>
  <last_update_submitted>February 22, 2013</last_update_submitted>
  <last_update_submitted_qc>February 22, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 25, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>San Gerardo Hospital</investigator_affiliation>
    <investigator_full_name>Pablo Mauricio Ingelmo M.D.</investigator_full_name>
    <investigator_title>Consultant Anesthesiologys. First Service of Anesthesia and Intensive Care</investigator_title>
  </responsible_party>
  <keyword>Laparoscopic</keyword>
  <keyword>Colectomy</keyword>
  <keyword>Nebulization</keyword>
  <keyword>Ropivacaine</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pain, Postoperative</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ropivacaine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

